Cardiotrack, a leading provider of data-centric healthcare screening technology and services, has achieved a significant milestone in its growth journey by securing $2 million in a pre-series A funding round. Led by Girish Narasimhan and co-investor Y S Shashidhar, this funding infusion underscores the recognition of Cardiotrack’s innovative approach to healthcare screening and its potential to transform the industry landscape.
Founded by Avin Agarwal, Cardiotrack specializes in delivering at-home pathology and radiology screening services across 300 locations in India. With a pan-India network of diagnostic centers, technicians, and phlebotomists equipped with its cutting-edge technology, Cardiotrack brings the convenience of medical examinations directly to individuals’ homes.
At the core of Cardiotrack’s offerings are its unique screening technologies, which provide the equivalent of a treadmill test in the comfort of one’s home. Through video-based recorded medical examinations and state-of-the-art diagnostics devices, Cardiotrack empowers individuals to take proactive control of their health while ensuring a seamless onboarding experience for health and life insurance providers.
The startup’s commitment to innovation extends to workflow automation and health data digitization solutions, enabling health and life insurance companies to enhance their offerings and deliver personalized services to their customers. With actionable insights into consumers’ health, Cardiotrack facilitates informed decision-making and promotes preventive healthcare practices.
Currently serving nine prominent health and life insurance companies in India, Cardiotrack has established itself as a trusted partner in the healthcare ecosystem. With the support of investors like Girish Narasimhan and Y S Shashidhar, the company is well-positioned to expand its reach and impact, ushering in a new era of accessible and personalized healthcare services.
As the healthcare industry continues to evolve, Cardiotrack remains at the forefront of innovation, driving positive change and empowering individuals to prioritize their health and well-being. With the infusion of funds from the pre-series A round, Cardiotrack is poised to accelerate its growth trajectory, revolutionizing healthcare screening and making a meaningful impact on the lives of millions.
